Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Trading Update

1 May 2026 07:00

RNS Number : 6971C
MJ Gleeson PLC
01 May 2026
 

 

MJ Gleeson plc 

("MJ Gleeson" or the "Group") 

 

Trading Update

MJ Gleeson plc is providing a trading update covering the 11 weeks to 24 April 2026 ("the Period").

 

Gleeson Homes

 

Trading

 

Gleeson Homes has experienced resilient trading through the period since 11 February, when the Group announced its H1 results. Net reservation rates for the 11 weeks to 24 April were 0.88 per site per week (0.59 excluding bulk reservations) compared to 0.86 per site per week (0.64 excluding bulk reservations) during the same period last year.

 

There has been modest build cost inflation since the start of the calendar year whilst underlying selling prices on open-market and partnership sales have been broadly stable. Protecting margin continues to be a priority.

 

Restructuring & legacy site cost provisions

 

Following the successful implementation of Project Transform, we continue to seek opportunities to improve the business, sharpening efficiency, mitigating overhead costs and focusing our investment into those regions and locations where we see optimal prospects for controlled growth.

 

From 1 July, the Yorkshire East region will be integrated into Yorkshire South and West. The creation of one Yorkshire region, and reallocation of certain sites into the Midlands region, will improve the efficiency of those regions, refocus our investment into higher return land opportunities and generate annualised regional overhead savings of £0.9m. The related costs are estimated at up to £3.1 million, comprising cash restructure costs of £0.3m and the non-cash impairment of certain conditionally purchased land assets of between £1.5m and £2.8m, and will be recognised as an exceptional item in the full-year accounts.

 

Our new management teams have identified issues on previously completed legacy developments, mainly in Yorkshire, which require rectification in order to achieve adoption of the roads (and other statutory services) by the relevant Local Authorities. As we work through these issues we expect to establish cost provisions in the current financial year estimated at between £5.2 million and £7.1 million, for remedial works to be undertaken over the next three to four years. It is expected that Adjusted results1 for the current financial year will exclude these legacy site provisions.

 

Gleeson Land

 

Gleeson Land continues to progress the sale of five sites including one site which represents approximately 50% of total plots forecast to be sold during the year. In respect of that project, we have made good progress on the required technical solution, which has now been accepted by the highways authority. The timing of conclusion of the sale is subject to formal technical approval. We will provide an update when we are clearer on that timing.

FY2026 outturn

 

With greater visibility across Gleeson Homes' Spring selling season and subject to Gleeson Land completing its major land sale, the Board expects that Adjusted Group Profit before Tax1 for the year ending 30 June 2026 will be in line with market consensus2.

 

Graham Prothero, CEO, commented:

 

"We are pleased that Gleeson Homes' trading performance has been resilient in an uncertain market environment.

 

"Whilst it is frustrating that further work is required on a number of legacy sites, I am pleased with the determination of our new management teams to identify and rectify legacy issues which now allows Gleeson Homes to look forward with confidence.

 

"It is too early to forecast the degree to which the crisis in the Middle East will impact customer confidence, mortgage affordability and build cost inflation over the coming months. We have recently seen some softening in footfall and reservations, and limited increases in the cost of some materials. This, together with ongoing challenges with planning and site viability, prompts even higher than usual caution in how we manage the business, including land investment decisions, into the next financial year.

 

"However, following the successful implementation of Project Transform, which has driven a greater focus on operational effectiveness and efficiency, the business as a whole is now in a much stronger position to manage through this period of uncertainty and capitalise on the significant opportunities we see ahead when the market returns to growth."

 

Graham Prothero, CEO, and Stefan Allanson, CFO, will host a conference call at 08:00 this morning. Institutional investors and analysts can register at mjgleeson@stoneway.co their interest in joining the call.

 

1 Adjusted Operating Profit and Adjusted Group Profit Before Tax will be determined in accordance with the Group's accounting policies and, while the classification of these costs remain under review, Adjusted Operating Profit and Adjusted Group Profit Before Tax are currently expected to exclude exceptional items and the additional completed site cost provisions which, in total, amount to between £7.0m and £10.2m. These adjustments are in addition to £0.3m exceptional items recognised in the interim results and the estimated £4.5m exceptional costs of restructuring the Greater Manchester Merseyside region announced in February 2026.

2 The company compiled consensus of Group Profit Before Tax and Exceptional items for the year ending 30 June 2026 is £18.2m with a range of £12.9m to £20.5m and can be found at: https://www.mjgleesonplc.com/investors/analyst-coverage/

 

Enquiries:

 

MJ Gleeson plc +44 1142 612 900

Graham Prothero, Chief Executive Officer

Stefan Allanson, Chief Financial Officer

 

Stoneway (Financial PR) mjgleeson@stoneway.co

Mark Garraway +44 7771 860938

Kim Looringh-van Beeck +44 20 3422 0208

 

Singer Capital Markets (Joint broker) +44 20 7496 3000

Shaun Dobson

Charles Leigh-Pemberton

 

Peel Hunt (Joint broker) +44 20 7418 8900

Ed Allsopp

Tom Graham

 

 

The information contained within this announcement was previously deemed by the Company to constitute inside information as stipulated by Market Abuse Regulation (EU) No 596/2014 ("EU MAR") and the retained UK law version of EU MAR pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2019 (SI 2019/310) ("UK MAR"). With the publication of this announcement via a Regulatory Information Service, this information is now considered to be in the public domain. For the purposes of UK MAR, the person responsible for arranging for the release of this information on behalf of MJ Gleeson plc is Stefan Allanson, Chief Financial Officer

LEI: 21380064K7N2W7FD6434

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTWPUBPCUPQPPU
Date   Source Headline
10th Jun 20197:00 amRNSRe Directorate
31st May 20197:00 amRNSTotal Voting Rights
30th May 20197:00 amRNSHolding(s) in Company
22nd May 20197:00 amRNSNotice of Site Visit
10th May 201910:52 amRNSDirector/PDMR Shareholding
2nd May 20197:00 amRNSSmaller related party land purchase
30th Apr 20197:00 amRNSTotal Voting Rights
29th Apr 201912:25 pmRNSDirector/PDMR Shareholding
1st Apr 20197:00 amRNSStatement re press speculation
29th Mar 20197:00 amRNSTotal Voting Rights
7th Mar 201911:16 amRNSDirector/PDMR Shareholding
28th Feb 20197:00 amRNSTotal Voting Rights
14th Feb 20197:00 amRNSHalf-year Report
8th Feb 201911:20 amRNSDirector/PDMR Shareholding
31st Jan 20197:00 amRNSTotal Voting Rights
8th Jan 20194:51 pmRNSDirector/PDMR Shareholding
7th Jan 20197:00 amRNSNotice of Results and Trading Update
31st Dec 20187:00 amRNSTotal Voting Rights
19th Dec 20184:35 pmRNSPrice Monitoring Extension
11th Dec 20189:16 amRNSDirector/PDMR Shareholding
7th Dec 201810:41 amRNSResult of AGM
6th Dec 20187:00 amRNSAGM Statement
30th Nov 20187:00 amRNSTotal Voting Rights
7th Nov 20189:50 amRNSDirector/PDMR Shareholding
5th Nov 20189:00 amRNSNotice of AGM
31st Oct 20187:00 amRNSTotal Voting Rights
10th Oct 20184:55 pmRNSPerformance Share Plan award to Directors/PDMRs
9th Oct 201812:01 pmRNSDirector/PDMR Shareholding
28th Sep 20187:00 amRNSTotal Voting Rights
17th Sep 20187:00 amRNSFinal Results
7th Sep 20189:50 amRNSDirector/PDMR Shareholding
31st Aug 20187:00 amRNSTotal Voting Rights
9th Aug 20187:00 amRNSDirector/PDMR Shareholding
31st Jul 20187:00 amRNSTotal Voting Rights
9th Jul 20189:05 amRNSDirector/PDMR Shareholding
5th Jul 20187:00 amRNSTrading Update
29th Jun 20187:00 amRNSTotal Voting Rights
6th Jun 20183:14 pmRNSDirector/PDMR Shareholding
31st May 20187:00 amRNSTotal Voting Rights
10th May 20189:57 amRNSDirector/PDMR Shareholding
30th Apr 20187:00 amRNSTotal Voting Rights
13th Apr 201811:32 amRNSDirector/PDMR Shareholding
6th Apr 201811:45 amRNSDirector/PDMR Shareholding
29th Mar 20187:00 amRNSTotal Voting Rights
12th Mar 201810:00 amRNSNotice of Results
6th Mar 20186:22 pmRNSDirector/PDMR Shareholding
1st Mar 20188:57 amRNSHolding(s) in Company
28th Feb 20185:45 pmRNSDirector/PDMR Shareholding
28th Feb 20187:00 amRNSTotal Voting Rights
20th Feb 201810:51 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.